Cargando…
Omics-Based Biomarkers: Application of Metabolomics in Neuropsychiatric Disorders
One of the major concerns of modern society is to identify putative biomarkers that serve as a valuable early diagnostic tool to identify a subset of patients with increased risk to develop neuropsychiatric disorders. Biomarker identification in neuropsychiatric disorders is proposed to offer a numb...
Autores principales: | Sethi, Sumit, Brietzke, Elisa |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4815467/ https://www.ncbi.nlm.nih.gov/pubmed/26453695 http://dx.doi.org/10.1093/ijnp/pyv096 |
Ejemplares similares
-
A Comprehensive Evaluation of Cross-Omics Blood-Based Biomarkers for Neuropsychiatric Disorders
por: Song, Weichen, et al.
Publicado: (2021) -
Apolipoprotein D as a Potential Biomarker in Neuropsychiatric Disorders
por: del Valle, Eva, et al.
Publicado: (2023) -
Small Molecules: Therapeutic Application in Neuropsychiatric and Neurodegenerative Disorders
por: Schiavone, Stefania, et al.
Publicado: (2018) -
Application of “omics” to Prion Biomarker Discovery
por: Huzarewich, Rhiannon L. C. H., et al.
Publicado: (2010) -
Behavioral metabolomics: how behavioral data can guide metabolomics research on neuropsychiatric disorders
por: van de Wetering, Ross, et al.
Publicado: (2023)